FDA makes packaging rules to limit opioid addiction and ODs

Publisher： John Wiley & Sons Inc

E-ISSN： 1556-7591|30|6|6-7

ISSN： 1042-1394

Source： ALCOHOLISM AND DRUG ABUSE WEEKLY, Vol.30, Iss.6, 2018-02, pp. : 6-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Study: Heroin ODs increase by 23 percent, Rx opioid ODs decrease by 20 percent

By  

ALCOHOLISM AND DRUG ABUSE WEEKLY, Vol. 27, Iss. 17, 2015-04 ,pp. : 7-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

Standards revisions for opioid addiction treatment and detox programs

By  

JCAH Perspectives, Vol. 22, Iss. 3, 2002-03 ,pp. : 4-4

Joint Commission Resources

Access to resources Recommend Favorite

How to decipher studies of addiction risks of opioid analgesia

By  

ALCOHOLISM AND DRUG ABUSE WEEKLY, Vol. 30, Iss. 6, 2018-02 ,pp. : 3-4

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA approves new indication — opioid withdrawal — for electric stimulation device

By  

THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol. 20, Iss. 1, 2018-01 ,pp. : 8-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA orders black box warnings for benzo‐opioid co‐Rx

By  

ALCOHOLISM AND DRUG ABUSE WEEKLY, Vol. 28, Iss. 35, 2016-09 ,pp. : 5-6

John Wiley & Sons Inc

Access to resources Recommend Favorite